Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062065
Company: SANDOZ
Company: SANDOZ
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NYSTATIN | NYSTATIN | 500,000 UNITS | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/16/1994 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/29/1995 | SUPPL-15 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/12/1996 | SUPPL-14 | Labeling |
Label is not available on this site. |
||
10/27/1994 | SUPPL-13 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/13/1995 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/27/1995 | SUPPL-11 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/12/1996 | SUPPL-10 | Labeling |
Label is not available on this site. |
||
09/11/1992 | SUPPL-9 | Labeling |
Label is not available on this site. |